Spinal cord injury (SCI) remains a life-altering event that devastates those injured and the
families that support them. Numerous laboratories are engaged in preclinical and clinical …

Spinal cord injury can attenuate both motor and sensory function with minimal potential for
full recovery. Research utilizing human induced pluripotent stem cell (hiPSC)-derived spinal …

Spinal cord injury (SCI) is a devastating neurological disorder that damages motor, sensory,
and autonomic pathways. Recent advances in stem cell therapy have allowed for the in vitro …

Traumatic spinal cord injury (SCI) is a leading cause of lifelong disabilities. Permanent
sensory, motor and autonomic impairments after SCI are substantially attributed to …

Due to the nature of the biological response to traumatic spinal cord injury, there are very
limited therapeutic options available to patients. Recent advances in cell transplantation …

Human neural stem cells (hNSCs) and human induced pluripotent stem cells (hiPSCs) have
been the primary focuses in basic science and translational research as well as in …

Spinal cord neural stem cells (NSCs) have great potential to reconstitute damaged spinal
neural circuitry, but they have yet to be generated in vitro. We now report the derivation of …

Neural stem cells (NSCs) from embryonic or fetal/adult tissue sources have shown
considerable promise in regenerative strategies for traumatic spinal cord injury (SCI) …

Neural cell interventions in spinal cord injury (SCI) have focused predominantly on
transplanted multipotent neural stem/progenitor cells (NSPCs) for animal research and …

Spinal cord injury (SCI) causes myelopathy, damage to white matter, and myelinated fiber
tracts that carry sensation and motor signals to and from the brain. The gray matter damage …